Investor Relations
May 18, 2018
OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test MORE >>
May 08, 2018
OPKO Health Reports First Quarter 2018 Financial Results MORE >>
May 02, 2018
OPKO Health to Announce First Quarter 2018 Financial Results on May 8, 2018 MORE >>
May 01, 2018
OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories MORE >>

Press Releases

All Releases
The Frost Group Invests $20 Million in OPKO Health
Dec 05, 2007
MIAMI, Dec 05, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- OPKO Health, Inc. (Amex: OPK) today announced that the members of The Frost Group, a private investment group controlled by Dr. Phillip Frost, Chairman and CEO of OPKO Health, have made a $20 million investment in OPKO.
OPKO Health Completes Acquisition of Ophthalmic Technologies, Inc.
Nov 29, 2007
MIAMI, Nov 29, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- OPKO Health Inc. (AMEX: OPK) today announced that it has completed the previously announced acquisition of Ophthalmic Technologies, Inc. (OTI), a privately owned Canadian company providing innovative ocular imaging systems to eye
OPKO Health Acquires Rights to Innovative Ocular Product to Prevent Serious Eye Infections
Oct 30, 2007
- Novel Ocular Product Is Specially Designed To Prevent Sight-Destroying Endophthalmitis - - Rising Number of Invasive Ocular Procedures and Use of Sutureless Ocular Surgery Are Associated With a Higher Incidence of Endophthalmitis -
OPKO Health Acquires Rights to Clinical Stage Compound for Dry Eye
Oct 10, 2007
MIAMI, Oct 10, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- OPKO Health Inc. (Amex: OPK) today announced that it has acquired exclusive worldwide rights for ophthalmic uses to a topical clinical stage compound with potential utility in the treatment of dry eye.
OPKO Health Appoints Pascal J. Goldschmidt To Board Of Directors
Oct 01, 2007
OPKO Health Appoints Pascal J. Goldschmidt To Board Of Directors MIAMI, FL– October 1, 2007– OPKO Health Inc. (AMEX: OPK) has announced the appointment of Pascal J. Goldschmidt, M.D. to its Board of Directors. Dr. Goldschmidt is the Senior Vice President for Medical Affairs and Dean of
OPKO Health to Present at UBS 2007 Global Life Sciences Conference
Sep 18, 2007
MIAMI, Sept. 18 /PRNewswire-FirstCall/ -- OPKO Health Inc. (Amex: OPK - News) today announced that it will present at the UBS 2007 Global Life Sciences Conference on Tuesday, September 25, 2007 at 11:30 am EDT. The conference will be held at the Grand Hyatt New York in New York City.
OPKO Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Aug 30, 2007
Groundbreaking Trial Is Designed to Compare Efficacy of Bevasiranib Administered Every 8 Weeks or 12 Weeks with Genentech's Lucentis® Administered Every 4 Weeks
OPKO Health, Inc. Announces Early Termination of Hart-Scott-Rodino Period for Proposed Purchase of Shares by Dr. Phillip Frost
Jul 12, 2007
Opko Health, Inc. Announces Early Termination of Hart-Scott-Rodino Period for Proposed Purchase of Shares by Dr. Phillip Frost MIAMI, FL– July 12, 2007– Opko Health Inc. (AMEX: OPK) today announced that that the U.S. Department of Justice has granted early termination of the waiting
OPKO Health Initiates Phase 3 Trial of Bevasiranib for the Treatment of AMD
Jul 11, 2007
-- Trial Designed to Compare Efficacy of Bevasiranib Administered Every 8 Weeks or 12 Weeks with Lucentis® Administered Every 4 Weeks --

-- Represents First-Ever Phase 3 Pivotal Trial of an RNAi Therapeutic --
Exegenics Changes Name to OPKO Health and Receives Approval for Its Shares to Trade on the American Stock Exchange Under the Symbol OPK
Jun 08, 2007
EXEGENICS CHANGES NAME TO OPKO HEALTH AND RECEIVES APPROVAL FOR ITS SHARES TO TRADE ON THE AMERICAN STOCK EXCHANGE UNDER THE SYMBOL OPK MIAMI, FL - June 8, 2007 - eXegenics, Inc. (OTC BB: EXEG) today announced that it has completed its name change to Opko Health Inc.
OPKO Health, Inc. to Acquire Diagnostic Imaging Firm
Jun 01, 2007
Hires Industry Veteran as Executive Vice President of Instrumentation
Exegenics, Inc. Announces Senior Management Appointments; Company Intends to Change its Name to OPKO Health
May 04, 2007
Exegenics, Inc. Announces Senior Management Appointments; Company Intends to Change its Name to OPKO Health MIAMI, FL?May 4, 2007? eXegenics, Inc., (OTC BB: EXEG), doing business as Opko Health, today announced appointment of its senior management team. Dr.
Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
Mar 27, 2007
Combined Company to be Re-Named Opko Corporation
Displaying 341 - 353 of 353